Brief: enGene Names Amy Pott As Chief Global Commercialization Officer
28/05/2025 12:35
May 28 (Reuters) - enGene Holdings Inc ENGN.O: ENGENE NAMES AMY POTT AS CHIEF GLOBAL COMMERCIALIZATION OFFICER Source text: ID:nBw2rfgQZa Further company coverage: ENGN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on enGene Therapeutics
See all newsBrief: Engene Reports Second Quarter 2026 Financial Results And Provides Business Update
enGene Therapeutics Inc expected to post a loss of 47 cents a share - Earnings Preview
Brief: Engene Holdings Inc - To Change Name To Engene Therapeutics Inc. Effective April 8, 2026
Brief: Engene Holdings Enters Sales Agreement With Leerink Partners To Sell Common Shares
Brief: enGene Reports First Quarter 2026 Financial Results and Provides Business Update